ILEX MEDICAL LTD Inactive Instrument
Ilex Medical Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
ILX
IL0010807530
Advanced Medical Equipment & Technology
| Sales 2022 | 873M 0 318M | Sales 2023 | 931M 0 339M | Capitalization | 663M 0 242M |
|---|---|---|---|---|---|
| Net income 2022 | 102M - 37.15M | Net income 2023 | 50M - 18.21M | EV / Sales 2022 | 1.04 x |
| Net cash position 2022 | 174M 0 63.43M | Net cash position 2023 | 169M 0 61.5M | EV / Sales 2023 | 0.53 x |
| P/E ratio 2022 |
10.6
x | P/E ratio 2023 |
12.9
x | Employees | - |
| Yield 2022 |
2% | Yield 2023 |
2.32% | Free-Float | 37.55% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Moshe Ben-Shaul
FOU | Founder | 81 | 76-12-31 |
Tamar Galili
CEO | Chief Executive Officer | 51 | 91-12-31 |
| Director of Finance/CFO | 51 | 22-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lihi Segal
BRD | Director/Board Member | 52 | 21-12-20 |
Moshe Ben-Shaul
FOU | Founder | 81 | 76-12-31 |
Lian Goldstein
BRD | Director/Board Member | 49 | 21-03-10 |
Ilex Medical Ltd is an Israel-based company active in the medical sector. It is a supplier of in vitro diagnostic equipment and laboratory management software. The Company offers cutting-edge diagnostic equipment and reagent systems; nucleic acid testing (NAT) blood screening solutions; products for cancer screening, retro virus load, TB, and STDs, and other infectious diseases; laboratory information systems (LIS); and blood sugar monitoring products. Among the Companyâs subsidiaries and affiliates are Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd and Medtechnica Ltd.
| 1st Jan change | Capi. | |
|---|---|---|
| +26.13% | 77.74M | |
| +20.00% | 65.56M |
